Filter
1264
Filtered Results: 1264
Text search:
European
Center
for
Disease
Prevention
and
Control
Featured
Recommendations
130
New Publications
214
Language
Document type
No document type
581
Studies & Reports
305
Guidelines
211
Manuals
80
Strategic & Response Plan
34
Fact sheets
23
Situation Updates
13
Training Material
8
Online Courses
3
Brochures
2
Resource Platforms
2
App
1
Videos
1
Countries / Regions
Global
54
Western and Central Europe
47
India
29
Ukraine
27
Eastern Europe
27
Russia
27
Latin America and the Carribbean
22
Africa
22
Sierra Leone
19
Liberia
18
Kenya
17
Ethiopia
16
Eastern Europe and Central Asia
13
Nepal
11
Germany
11
Zambia
11
Myanmar / Burma
11
Philippines
10
Brazil
10
Nigeria
9
Uganda
9
Rwanda
9
Guinea
8
Senegal
8
Syria
8
Indonesia
8
Middle East and North Africa
8
Asia
8
Albania
8
Burkina Faso
7
Mozambique
7
West and Central Africa
7
South–East Asia Region
7
Zimbabwe
6
South Sudan
6
Cambodia
6
South Africa
6
Georgia
6
Tanzania
5
Thailand
5
Yemen
5
East and Southern Africa
5
Congo, Democratic Republic of
4
Ghana
4
Bangladesh
4
Malawi
4
Angola
4
Moldova
4
USA
3
Pakistan
3
Jordan
3
Afghanistan
3
Argentina
3
Namibia
3
Eswatini/ Swaziland
3
North Macedonia
3
Colombia
3
Western Pacific Region
3
Armenia
3
Tajikistan
3
Vietnam
3
France
3
Belarus
3
Guinea-Bissau
2
Cameroon
2
Haiti
2
Somalia
2
Turkey
2
Benin
2
Central African Republic
2
Ecuador
2
Bolivia
2
Lesotho
2
Sri Lanka
2
Chile
2
Paraguay
2
Venezuela
2
Laos
2
Romania
2
Kazakhstan
2
Gabon
2
Jamaica
2
United Kingdom
2
Spain
2
Saudi Arabia
1
Iraq
1
Lebanon
1
Egypt
1
China
1
Papua New Guinea
1
Sudan
1
Peru
1
Hungary
1
Honduras
1
El Salvador
1
Greece
1
Madagascar
1
Other region
1
Bhutan
1
Poland
1
Italy
1
Qatar
1
Estonia
1
Lithuania
1
Iran
1
North America
1
Turkmenistan
1
Belgium
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
305
Clinical Guidelines
117
Public Health
86
Key Resources
53
Women & Child Health
42
Pharmacy & Technologies
13
Capacity Building
11
Toolboxes
COVID-19
160
Mental Health
153
HIV
135
AMR
90
TB
84
Rapid Response
53
Planetary Health
48
NCDs
43
Ebola
36
Global Health Education
30
Caregiver
30
Refugee
23
Conflict
21
Pharmacy
21
Health Financing Toolbox
21
Disability
20
NTDs
19
Zika
13
Specific Hazards
8
Natural Hazards
6
Cholera
5
Polio
3
Social Ethics
2
Health Financing
1
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amid...
International Journal of Infectious Diseases 32 (2015) 111–117
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased ...
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) fosters cooperation between the European Union (EU) andthe United States (US) on the issue of antimicrobial resistance. The first TATFAR recommendation refers to appropriate use of an...
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity ... Surveillance and Response Program
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, ... South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nC...
Growing evidence indicates that large proportions of children around the world experience physical, sexual and emotional violence every year, with enormous implications for human rights, public heal...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However...
This guidance provides an overview of interventions to improve early diagnosis of TB and treatment completion in these populations, as well as factors to consider when developing programmes for heal...
This 400 page guide, created by PHI’s Center for Climate Change and Health and the American Pu...
Extreme heat events (EHEs) are a leading cause of weather-related injury and death in the United States, and under a changing climate, these meteorological episodes are predicted to increase in both...
This European compendium was produced to provide operational examples of the new nursing and midwifery roles and new service delivery models curren...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care ... prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support countries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.
This guide contains recommendations for health and safety practices and approaches to COVID-19 preventi..., based on materials developed by many organisations.
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people w...
